Literature DB >> 31334584

Genome-wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine-phosphate-guanine methylation and histological subtypes.

David Fiedler1, Daniela Hirsch1, Nady El Hajj2,3, Howard H Yang4, Yue Hu5, Carsten Sticht6, Indrajit Nanda2, Sebastian Belle7,8, Josef Rueschoff9, Maxwell P Lee4, Thomas Ried5, Thomas Haaf2, Timo Gaiser1.   

Abstract

Aberrant methylation of DNA is supposed to be a major and early driver of colonic adenoma development, which may result in colorectal cancer (CRC). Although gene methylation assays are used already for CRC screening, differential epigenetic alterations of recurring and nonrecurring colorectal adenomas have yet not been systematically investigated. Here, we collected a sample set of formalin-fixed paraffin-embedded colorectal low-grade adenomas (n = 72) consisting of primary adenomas without and with recurrence (n = 59), recurrent adenomas (n = 10), and normal mucosa specimens (n = 3). We aimed to unveil differentially methylated CpG positions (DMPs) across the methylome comparing not only primary adenomas without recurrence vs primary adenomas with recurrence but also primary adenomas vs recurrent adenomas using the Illumina Human Methylation 450K BeadChip array. Unsupervised hierarchical clustering exhibited a significant association of methylation patterns with histological adenoma subtypes. No significant DMPs were identified comparing primary adenomas with and without recurrence. Despite that, a total of 5094 DMPs (false discovery rate <0.05; fold change >10%) were identified in the comparisons of recurrent adenomas vs primary adenomas with recurrence (674; 98% hypermethylated), recurrent adenomas vs primary adenomas with and without recurrence (241; 99% hypermethylated) and colorectal adenomas vs normal mucosa (4179; 46% hypermethylated). DMPs in cytosine-phosphate-guanine (CpG) islands were frequently hypermethylated, whereas open sea- and shelf-regions exhibited hypomethylation. Gene ontology analysis revealed enrichment of genes associated with the immune system, inflammatory processes, and cancer pathways. In conclusion, our methylation data could assist in establishing a more robust and reproducible histological adenoma classification, which is a prerequisite for improving surveillance guidelines.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA methylation; adenoma; epigenetics; histological subtype; recurrence

Mesh:

Substances:

Year:  2019        PMID: 31334584      PMCID: PMC8268761          DOI: 10.1002/gcc.22787

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   4.263


  51 in total

Review 1.  Epigenetics in cancer.

Authors:  Manel Esteller
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

2.  [S3-guideline colorectal cancer version 1.0].

Authors:  C Pox; S Aretz; S C Bischoff; U Graeven; M Hass; P Heußner; W Hohenberger; A Holstege; J Hübner; F Kolligs; M Kreis; P Lux; J Ockenga; R Porschen; S Post; N Rahner; A Reinacher-Schick; J F Riemann; R Sauer; A Sieg; W Scheppach; W Schmitt; H J Schmoll; K Schulmann; A Tannapfel; W Schmiegel
Journal:  Z Gastroenterol       Date:  2013-08-16       Impact factor: 2.000

3.  DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.

Authors:  Hassan Ashktorab; M Daremipouran; Ajay Goel; Sudhir Varma; R Leavitt; Xueguang Sun; Hassan Brim
Journal:  Epigenetics       Date:  2014-01-17       Impact factor: 4.528

Review 4.  DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.

Authors:  Melina-Theoni Gyparaki; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  J Mol Med (Berl)       Date:  2013-09-21       Impact factor: 4.599

5.  Interlaboratory variability in the grading of dysplasia in a nationwide cohort of colorectal adenomas.

Authors:  Chantal C H J Kuijpers; Caro E Sluijter; Jan H von der Thüsen; Katrien Grünberg; Martijn G H van Oijen; Paul J van Diest; Mehdi Jiwa; Iris D Nagtegaal; Lucy I H Overbeek; Stefan M Willems
Journal:  Histopathology       Date:  2016-02-14       Impact factor: 5.087

6.  Adenoma detection rate and risk of colorectal cancer and death.

Authors:  Douglas A Corley; Christopher D Jensen; Amy R Marks; Wei K Zhao; Jeffrey K Lee; Chyke A Doubeni; Ann G Zauber; Jolanda de Boer; Bruce H Fireman; Joanne E Schottinger; Virginia P Quinn; Nirupa R Ghai; Theodore R Levin; Charles P Quesenberry
Journal:  N Engl J Med       Date:  2014-04-03       Impact factor: 91.245

7.  Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains.

Authors:  Vardhman K Rakyan; Thomas A Down; Siarhei Maslau; Toby Andrew; Tsun-Po Yang; Huriya Beyan; Pamela Whittaker; Owen T McCann; Sarah Finer; Ana M Valdes; R David Leslie; Panogiotis Deloukas; Timothy D Spector
Journal:  Genome Res       Date:  2010-03-10       Impact factor: 9.043

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.

Authors:  Angeline S Andrew; John A Baron; Lynn F Butterly; Arief A Suriawinata; Gregory J Tsongalis; Christina M Robinson; Christopher I Amos
Journal:  Int J Mol Sci       Date:  2017-03-02       Impact factor: 5.923

10.  Practical implementation of DNA methylation and copy-number-based CNS tumor diagnostics: the Heidelberg experience.

Authors:  David Capper; Damian Stichel; Felix Sahm; David T W Jones; Daniel Schrimpf; Martin Sill; Simone Schmid; Volker Hovestadt; David E Reuss; Christian Koelsche; Annekathrin Reinhardt; Annika K Wefers; Kristin Huang; Philipp Sievers; Azadeh Ebrahimi; Anne Schöler; Daniel Teichmann; Arend Koch; Daniel Hänggi; Andreas Unterberg; Michael Platten; Wolfgang Wick; Olaf Witt; Till Milde; Andrey Korshunov; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2018-07-02       Impact factor: 17.088

View more
  7 in total

Review 1.  [Colorectal tumor evolution in inflammatory bowel disease : Dynamics of genomic alterations and potential molecular markers to predict malignant progression].

Authors:  D Hirsch
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

2.  Genome-wide methylation profiling of early colorectal cancer using an Illumina Infinium Methylation EPIC BeadChip.

Authors:  Yu-Ling Wu; Tao Jiang; Wei Huang; Xing-Yu Wu; Peng-Jun Zhang; Ya-Ping Tian
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

3.  Promoter Methylation of QKI as a Potential Specific Biomarker for Early Detection of Colorectal Cancer.

Authors:  Lei Zhang; Dapeng Li; Lijing Gao; Jinming Fu; Simin Sun; Hao Huang; Ding Zhang; Chenyang Jia; Ting Zheng; Binbin Cui; Yanlong Liu; Yashuang Zhao
Journal:  Front Genet       Date:  2022-08-09       Impact factor: 4.772

4.  Hypermethylation of tumor suppressor lncRNA MEF2C-AS1 frequently happened in patients at all stages of colorectal carcinogenesis.

Authors:  Sangni Qian; Shujuan Lin; Xin Xu; Mingjuan Jin; Kun Chen; Hao Bai; Aibuta Yeerken; Xiaojiang Ying; Zhenjun Li; Xinglin Fei; Jinhua Yang; Mengling Tang; Jianbing Wang
Journal:  Clin Epigenetics       Date:  2022-09-05       Impact factor: 7.259

5.  SCTR hypermethylation is a diagnostic biomarker in colorectal cancer.

Authors:  DaPeng Li; Lei Zhang; JinMing Fu; Hao Huang; SiMin Sun; Ding Zhang; LiYuan Zhao; Justina Ucheojor Onwuka; YaShuang Zhao; BinBin Cui
Journal:  Cancer Sci       Date:  2020-10-08       Impact factor: 6.716

6.  Epigenome-Wide DNA Methylation Profiling in Colorectal Cancer and Normal Adjacent Colon Using Infinium Human Methylation 450K.

Authors:  Rashidah Baharudin; Muhiddin Ishak; Azliana Muhamad Yusof; Sazuita Saidin; Saiful Effendi Syafruddin; Wan Fahmi Wan Mohamad Nazarie; Learn-Han Lee; Nurul-Syakima Ab Mutalib
Journal:  Diagnostics (Basel)       Date:  2022-01-14

7.  Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction.

Authors:  Tiziana Venesio; Daniela Furlan; Carla Debernardi; Laura Libera; Enrico Berrino; Nora Sahnane; Anna Maria Chiaravalli; Cristiana Laudi; Mattia Berselli; Anna Sapino; Fausto Sessa
Journal:  Clin Epigenetics       Date:  2021-08-09       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.